Clinical Trial Update: Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating paclitaxel with trastuzumab (Herceptin) in women with HER2-positive, early-stage breast cancer that is palpable and resectable. The r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2/Neu Positive, Stage IA Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-09-29